272 related articles for article (PubMed ID: 33745988)
1. Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
DeMeo DL
Chest; 2021 Jul; 160(1):104-113. PubMed ID: 33745988
[TBL] [Abstract][Full Text] [Related]
2. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
Milne S; Sin DD
Clin Chest Med; 2020 Sep; 41(3):383-394. PubMed ID: 32800193
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for precision medicine in airways disease.
Rooney C; Sethi T
Ann N Y Acad Sci; 2015 Jun; 1346(1):18-32. PubMed ID: 26099690
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
[TBL] [Abstract][Full Text] [Related]
6. The Challenges of Precision Medicine in COPD.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease in women: exploring gender differences.
Varkey AB
Curr Opin Pulm Med; 2004 Mar; 10(2):98-103. PubMed ID: 15021178
[TBL] [Abstract][Full Text] [Related]
8. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
[TBL] [Abstract][Full Text] [Related]
9. The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.
Rennard SI
Semin Respir Crit Care Med; 2015 Aug; 36(4):478-90. PubMed ID: 26238636
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Biomarkers Based on Proteomic Technology in COPD: A Recent Review.
Fang H; Liu Y; Yang Q; Han S; Zhang H
Int J Chron Obstruct Pulmon Dis; 2023; 18():1353-1365. PubMed ID: 37408604
[TBL] [Abstract][Full Text] [Related]
11. Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.
Evans RA
Chron Respir Dis; 2016 Aug; 13(3):284-5. PubMed ID: 27488126
[No Abstract] [Full Text] [Related]
12. Airway inflammation in COPD: progress to precision medicine.
Brightling C; Greening N
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073084
[TBL] [Abstract][Full Text] [Related]
13. Personalised pulmonary rehabilitation in COPD.
Wouters EFM; Wouters BBREF; Augustin IML; Houben-Wilke S; Vanfleteren LEGW; Franssen FME
Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29592864
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine in chronic obstructive pulmonary disease.
Halpin DMG
Chin Med J (Engl); 2022 May; 135(10):1156-1162. PubMed ID: 35787584
[TBL] [Abstract][Full Text] [Related]
15. Sex and Gender Differences in Lung Cancer and Chronic Obstructive Lung Disease.
Siegfried JM
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34927202
[TBL] [Abstract][Full Text] [Related]
16. Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
Bihlet AR; Karsdal MA; Bay-Jensen AC; Read S; Kristensen JH; Sand JMB; Leeming DJ; Andersen JR; Lange P; Vestbo J
Chest; 2015 Jul; 148(1):16-23. PubMed ID: 25856563
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis.
Ntritsos G; Franek J; Belbasis L; Christou MA; Markozannes G; Altman P; Fogel R; Sayre T; Ntzani EE; Evangelou E
Int J Chron Obstruct Pulmon Dis; 2018; 13():1507-1514. PubMed ID: 29785100
[TBL] [Abstract][Full Text] [Related]
18. Introduction to precision medicine in COPD.
Leung JM; Obeidat M; Sadatsafavi M; Sin DD
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30679189
[TBL] [Abstract][Full Text] [Related]
19. Airway Inflammation Biomarker for Precise Management of Neutrophil-Predominant COPD.
Liang X; Liu T; Zhang Z; Yu Z
Methods Mol Biol; 2020; 2204():181-191. PubMed ID: 32710325
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
